Skip to main content
Pills

The Solution to Soaring Drug Prices? A Public Option for Pills

Vishal Khetpal writes how with public opinion of Big Pharma near an all-time low, it’s time for the government to enter the generic drug business, citing The Democracy Collaborative’s report “Medicine for All.”

With prescription drug costs continuing to grow, lawmakers on both sides of the aisle have proposed pegging drug prices to an international index and granting states permission to import drugs from Canada. Among the public, both Democrats and Republicans have shown support for allowing Medicare to negotiate drug prices with pharmaceutical companies. But the moment might be ripe for an even bolder idea: letting the federal government get into the business of generic drug manufacturing, essentially creating a public option for generic drugs.

The idea isn’t new. Already, a group of large, private health care providers has come together to develop a not-for-profit generic drug manufacturer, called Civica Rx. And government-run drug manufacturing was proposed in a 2018 bill co-sponsored by Senator Elizabeth Warren, who has also included it in her campaign platform on health care. The nonprofit Democracy Collaborative recently commissioned a comprehensive report examining the idea, and just last month, California Governor Gavin Newsom announced a plan for the state to create its own generic drug label.

Read the entire article on Undark, or Salon.

Publication date: 2020-03-02
Parent publication: Salon
Publication URL: https://www.salon.com/2020/03/01/the-solution-to-soaring-drug-prices-a-public-option-for-pills_partner/

More related work

Default Image

The Democracy Collaborative and The Democracy Collaborative Workers' Union agree to fair severance package for laid-off staff

TDC and union members have agreed to a package of protections that goes well beyond the baseline severance provisions for layoffs agreed to in TDC’s union contract.

read more
Default Image

HAN Anchoring Resilience: Aligning Supply Chains and Impact Purchasing for Community Health summit

Today the Healthcare Anchor Network (HAN) convened the Anchoring Resilience: Aligning Supply Chains and Impact Purchasing for Community Health summit to catalyze the conversation around how the healthcare sector could collaborate to more intentionally onshore and localize production of PPE and other important supplies with emphasis on equity, sustainability, and supply chain resilience. HAN released a white paper “Reimagining Personal Protective Equipment (PPE) Supply Chains” that calls for national leadership and healthcare sector collaboration to create PPE production capacity for American sourced and manufactured supplies.

read more
Default Image

Reimagining Personal Protective Equipment (PPE) Supply Chains

The Democracy Collaborative prepared a report, created for the Healthcare Anchor Network, which details the current status of the supply chain of PPE, the market shifts caused by COVID-19, and the potential solutions to ensure capacity within US health systems for the future.

read more